Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 1366
The Company has the exclusive use of its intellectual property in the field of treating brain cancer related to the production of Lotrex, which is a component of the GliaSite Radiation Therapy System.
Lotrex is a radioactive liquid solution used in the treatment of brain cancer.
IPSCIO Record ID: 1370
Licensor is willing to grant Licensee rights to the Licensor IP in the Territory with a limited field of use of intracavity radiation therapy (brachytherapy) of the brain (â€œExclusive Field of Useâ€).
GliaSiteÂ® Radiation Therapy System (RTS) is for the treatment of brain cancer, i.e. primary and recurrent gliomas and metastic brain tumors. Specifically, the intended use of GliaSiteÂ® RTS is the management of surgically resectable brain tumors where adjuvant radiation therapy of the post-resection tissue bed is indicated.
IPSCIO Record ID: 1054
Its intended use is as a means of micro-arterial brachytherapy in the treatment of soft tissue cancer tumors in the liver. Soft tissue tumors are connected to the blood supply and this kind of therapy is administered through the blood supply system. Soft tissue tumors are among the most difficult forms of cancer to treat.
IPSCIO Record ID: 28028
United States Patent Application Serial Number 60/479,832 Date Filed 6/20/2003 Title 'Instant microspheres for microarterial imaging and radiotherapy'